Molecular and cellular mechanisms underlying brain metastasis of breast cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular and cellular mechanisms underlying brain metastasis of breast cancer
Authors
Keywords
-
Journal
CANCER AND METASTASIS REVIEWS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-13
DOI
10.1007/s10555-020-09881-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications
- (2019) Adrienne Boire et al. NEURO-ONCOLOGY
- TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases
- (2019) Rachel A. Freedman et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II study of abemaciclib in patients (pts) with brain metastases (BM) secondary to HR+, HER2- metastatic breast cancer (MBC).
- (2019) Carey K. Anders et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma
- (2019) Dieter Henrik Heiland et al. Nature Communications
- Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
- (2019) Rashmi K. Murthy et al. NEW ENGLAND JOURNAL OF MEDICINE
- External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience
- (2018) Gaia Griguolo et al. BREAST
- Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
- (2018) Georgina V Long et al. LANCET ONCOLOGY
- STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis
- (2018) Neibla Priego et al. NATURE MEDICINE
- HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer
- (2018) Mari Hosonaga et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Variation among intact tissue samples reveals the core transcriptional features of human CNS cell classes
- (2018) Kevin W. Kelley et al. NATURE NEUROSCIENCE
- Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
- (2018) Hussein A. Tawbi et al. NEW ENGLAND JOURNAL OF MEDICINE
- PI3K: A master regulator of brain metastasis-promoting macrophages/microglia
- (2018) Raquel Blazquez et al. GLIA
- Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
- (2018) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reactive Astrocytes: Production, Function, and Therapeutic Potential
- (2017) Shane A. Liddelow et al. IMMUNITY
- Neurotoxic reactive astrocytes are induced by activated microglia
- (2017) Shane A. Liddelow et al. NATURE
- Identification of diverse astrocyte populations and their malignant analogs
- (2017) Chia-Ching John Lin et al. NATURE NEUROSCIENCE
- Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
- (2017) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation
- (2017) David P. Kodack et al. Science Translational Medicine
- RNA Sequencing Analysis Reveals Interactions between Breast Cancer or Melanoma Cells and the Tissue Microenvironment during Brain Metastasis
- (2017) Ryo Sato et al. Biomed Research International
- Reactive Astrocytes in Brain Metastasis
- (2017) David Wasilewski et al. Frontiers in Oncology
- Dose-escalation study for the targeting of CD44v+ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205)
- (2016) Kohei Shitara et al. Gastric Cancer
- Intrathecal Trastuzumab Halts Progression of CNS Metastases in Breast Cancer
- (2016) Guilhem Bousquet et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
- (2016) Sarah B Goldberg et al. LANCET ONCOLOGY
- PI3Kγ is a molecular switch that controls immune suppression
- (2016) Megan M. Kaneda et al. NATURE
- Carcinoma–astrocyte gap junctions promote brain metastasis by cGAMP transfer
- (2016) Qing Chen et al. NATURE
- Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases
- (2016) Jing Ni et al. NATURE MEDICINE
- MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis
- (2016) A Ghoochani et al. ONCOGENE
- PTEN mediates the cross talk between breast and glial cells in brain metastases leading to rapid disease progression
- (2016) Ina Hohensee et al. Oncotarget
- Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization
- (2015) Yujeong Lee et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance
- (2015) Jodi M Saunus et al. JOURNAL OF PATHOLOGY
- Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
- (2015) Lin Zhang et al. NATURE
- Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases
- (2015) Anna S Berghoff et al. OncoImmunology
- Reactive Astrocytes Protect Melanoma Cells from Chemotherapy by Sequestering Intracellular Calcium through Gap Junction Communication Channels
- (2015) Qingtang Lin et al. NEOPLASIA
- Astrocytes Upregulate Survival Genes in Tumor Cells and Induce Protection from Chemotherapy
- (2015) Sun-Jin Kim et al. NEOPLASIA
- Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis
- (2014) Manuel Valiente et al. CELL
- PI3K isoform dependence of PTEN-deficient tumors can be altered by the genetic context
- (2014) F. Schmit et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+T cells
- (2014) Debbie C Strachan et al. OncoImmunology
- Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab
- (2013) E. M. Olson et al. ANNALS OF ONCOLOGY
- xCT Inhibition Depletes CD44v-Expressing Tumor Cells That Are Resistant to EGFR-Targeted Therapy in Head and Neck Squamous Cell Carcinoma
- (2013) M. Yoshikawa et al. CANCER RESEARCH
- Two Birds with One Stone: Dual p110δ and p110γ Inhibition
- (2013) Klaus Okkenhaug CHEMISTRY & BIOLOGY
- Rebuilding cancer metastasis in the mouse
- (2013) Meera Saxena et al. Molecular Oncology
- Heterogeneity of reactive astrocytes
- (2013) Mark A. Anderson et al. NEUROSCIENCE LETTERS
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases
- (2012) D. P. Kodack et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell
- (2012) Toshifumi Yae et al. Nature Communications
- CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc− and Thereby Promotes Tumor Growth
- (2011) Takatsugu Ishimoto et al. CANCER CELL
- Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases
- (2011) Paul W. Sperduto et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
- (2011) Paul W. Sperduto et al. JOURNAL OF CLINICAL ONCOLOGY
- The PD-1 pathway in tolerance and autoimmunity
- (2010) Loise M. Francisco et al. IMMUNOLOGICAL REVIEWS
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy
- (2008) S. T. Lee-Hoeflich et al. CANCER RESEARCH
- The xc− cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases
- (2008) Maisie Lo et al. JOURNAL OF CELLULAR PHYSIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now